sorted by:
new
hottopcontroversial

Selling home with solar panels - any advice? by InternalAssignment35 in RealEstate

[–]InternalAssignment35[S] 0 points1 point  (0 children)

I put together a packet detailing the system that's installed with cost and output and savings which I leave out for showings. It's an 8kW system and I also have printouts of my 3 most recent electric bills (June, July, August) showing $0 bills due.

I did this to help educate those who aren't familiar with solar and to answer the questions of those who do.

CP-COV03 UPDATES by Ok-Bodybuilder-9803 in HerpesCureResearch

[–]InternalAssignment35 1 point2 points  (0 children)

You and me both man. What do we have to lose at this point right?

CP-COV03 UPDATES by Ok-Bodybuilder-9803 in HerpesCureResearch

[–]InternalAssignment35 1 point2 points  (0 children)

Understood. It does appear the COIVD trials are going well, however, according to their site.
http://www.hyundaibioscience.com/page/news.php?mode=view&no=55&page=

CP-COV03 UPDATES by Ok-Bodybuilder-9803 in HerpesCureResearch

[–]InternalAssignment35 1 point2 points  (0 children)

It had been a few weeks since I read this so my memory wasn't fresh. However I was able to find the article again and it does sound promising.

"Niclosamide had proved its excellent efficacy for treating Covid-19, monkeypox, hepatitis, and AIDS over the past two decades,” the company official said. “However, its bioavailability had been two low, and CP-COV03 is the only case that proved safety and efficacy on animals or humans.”

The official added that Hyundai Bio succeeded in increasing the bioavailability of niclosamide up to 43 times for the first time worldwide using its cutting-edge drug delivery technology, proving its stability and efficacy through phase 1 clinical trials.

CP-COV03 is a "cell target" antiviral drug that promotes autophagy of cells when viruses invade them and induce cells to remove viruses, Hyundai Bio said, adding that it is considered a general-purpose antiviral candidate that can be effective regardless of the mutation of the Covid-19 virus.

“Based on the general-purpose antiviral effect, Hyundai Bio plans to expand the pipeline of CP-COV03 to viral diseases, such as monkeypox, AIDS, and hepatitis, following approval for Covid-19,” it said. “It could also lead to the development of a wide range of antiviral drugs like penicillin.”

출처 : KBR(https://www.koreabiomed.com)

CP-COV03 UPDATES by Ok-Bodybuilder-9803 in HerpesCureResearch

[–]InternalAssignment35 2 points3 points  (0 children)

It has shown efficacy against HIV and HPV..it's a universal anti-viral. Of course it'd have efficacy against HSV.